Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Valocor Therapeutics Inc.

Division of Dermira Inc.
www.valocor.com

Latest From Valocor Therapeutics Inc.

Financings Of The Fortnight: Corporate Venture Contributing In A Big Way

Once an unlikely scenario, corporate venture funds now are making up a larger and larger part of investment rounds for early-stage biotechs; these investments are buoyed by VCs launching their own firms. Plus news on recent financing activity from Avaxia Biologics, Clovis Oncology, Protagonist Therapeutics and Dermira.

BioPharmaceutical North America

Start-Up Quarterly Statistics, Q4 2011

Biopharma start-ups raised $693 million in Q4 2011, up 131% from Q3. Device companies brought in $111 million, and diagnostics firms raised $120 million total, $96 million of which was from Biocartis’ Series C. Cancer was the most prevalent therapeutic area for biopharma alliances. And in great contrast to Q3’s one M&A deal involving a start-up company, Q4 saw nine start-up acquisitions.

BioPharmaceutical Medical Device

Start-Up Quarterly Statistics, Q2 2010

Highlights from the Q2 2010 review of start-up dealmaking: Biopharma, medical device and in vitro diagnostics startups raised a total of $606 million, an 83% hike from the previous quarter but a 30% drop from Q2 2009. Unlike Q1, which saw four spin-offs, Q2 had just one. Three acquisitions closed including J&J's purchase of respiratory-focused RespiVert. During the second quarter of 2010, several companies signed multiple agreements including Clovis Oncology.
BioPharmaceutical Medical Device

Recent Financings of Private Companies (07/10)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Inflammation
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Dermira Inc.
  • Senior Management
  • Daniel Wattier, Pres. & CEO
    David Hunt, VP, Research
  • Contact Info
  • Valocor Therapeutics Inc.
    777 Dunsmuir St.
    Ste. 1300
    Vancouver,
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register